Breastcancer.org Podcast

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, talks about four studies that were presented at the 2015 San Antonio Breast Cancer Symposium, December 8-12, including studies that offer encouraging news about treatment for women diagnosed with triple-negative disease and metastatic, HER2-positive breast cancer. Listen to the podcast to hear Dr. Wojciechowski explain: what luminal A breast cancer is and why women diagnosed with this subtype didn’t seem to benefit from chemotherapy after surgery why adding carboplatin to a standard chemotherapy before surgery for triple-negative breast cancer improved pathologic complete response rates and what this means for women with triple-negative disease why postmenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer who are taking an aromatase inhibitor and have experienced bone loss might want to consider taking the targeted therapy denosumab results showing that Kadcyla improves overall survi